Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design.

@article{Bhler1999BetaxololVC,
  title={Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design.},
  author={Susanne B{\"o}hler and S Saubadu and R G Scheldewaert and Hans R. Figulla},
  journal={Arzneimittel-Forschung},
  year={1999},
  volume={49 4},
  pages={311-7}
}
The use of beta-blockers in heart failure for a long time was regarded as contra-indicated because of their negative inotropic effects. Nevertheless, there is growing evidence that beta-blockers slow down the progression of left ventricular dilatation that characterizes heart failure. In addition changes in left ventricular ejection fraction after several… CONTINUE READING